Karen Carey

Money, Experience Drawing Foreign Companies To U.S.

July 11, 2005

By Karen Carey

GSK Options In For HGS's LymphoStat-B For RA, SLE

July 8, 2005

By Karen Carey

SGX In $15M Research Deal For CF Mutation Correctors

July 7, 2005

By Karen Carey

Finding Post-IPO Liquidity In An 'Unpromised Land'

July 4, 2005

By Karen Carey

Alkermes Selects Cephalon As Vivitrex Partner In $480M Deal

June 27, 2005

By Karen Carey

A little more than two months after filing for approval of Vivitrex, Alkermes Inc. partnered the alcohol-dependence drug with Cephalon Inc. in a 50-50 profit-sharing deal worth an additional $480 million in up-front and milestone payments. (BioWorld Today)

Balboa Vs. Apollo: The Fight For Biotech Funding Continues

June 23, 2005

By Karen Carey

PHILADELPHIA - A disease of epidemic proportions hit Room 103A at the Pennsylvania Convention Center on Wednesday, the last day of the Biotechnology Industry Organization's annual international convention here. (BioWorld Today)